Bergers Lab Flanders Institute for Biotechnology
Responsible
Conducting a comprehensive investigation that defines the dialogues of heterogeneous tumor cell subtypes, and the vasculature and immune cells in the distinct tumor vascular niches in response during progression as well as targeted therapies including antiangiogenic and immune-modulating therapies.